Advertisement

Topics

Oxford Genetics secures investment; expands UK facility and eyes US market

07:56 EDT 23 Aug 2017 | BioPharma-Reporter

Oxford Genetics will expand its bioproduction services in the UK and target the US market through an office in Boston after receiving a £7.5m ($9.6m) investment.

Original Article: Oxford Genetics secures investment; expands UK facility and eyes US market

NEXT ARTICLE

More From BioPortfolio on "Oxford Genetics secures investment; expands UK facility and eyes US market"

Quick Search
Advertisement